TI
ANIK icon

Turner Investments’s Anika Therapeutics ANIK Stock Holding History

Turner Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-45,000
Closed -$2.41M – 186
2016
Q2 		$2.41M Buy
+45,000
New +$2.12M 0.76% 46

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Turner Investments's ANIK Position: Q3 2016 in Review

Turner Investments sold out of Anika Therapeutics (ANIK) in Q3 2016, closing a stake of 45,000 shares — an estimated $2.41M sold.

Turner Investments first reported a position in ANIK in Q2 2016 and held it in 1 quarter. The position peaked at $2.41M in Q2 2016. 163 funds tracked by Wall St. Rank hold ANIK as of Q3 2016.

  • Turner Investments reported no remaining Anika Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Turner Investments sold 45,000 Anika Therapeutics shares in Q3 2016, an estimated $2.41M.
  • Turner Investments first reported a position in Anika Therapeutics in Q2 2016 and held it in 1 quarter.
  • Turner Investments's Anika Therapeutics position peaked at $2.41M in Q2 2016.
  • 163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2016.

Based on Turner Investments's 13F filing for Q3 2016, filed 14 Nov 2016.